Aedifica NV/SA (EBR: AED) Stock Analysis & Fundamentals

AEDAedifica NV/SA

EBR · BE · Real Estate · REIT - Healthcare Facilities · aedifica.eu

70.60EUR-1.81%Mkt Cap: 6.41B $P/E: 6.141d ago

Aedifica NV/SA is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. Aedifica has built a real estate portfolio worth approximately 1…

Industry Peers

REIT - Healthcare Facilities

Screen all

vs REIT - Healthcare Facilities

P/E

Cheaper

P/B

Cheaper

Div Yield

Avg

1M Perf

Higher

Omega Healthcare Investors, Inc.

$14.87BUSDP/E 23.0

DOC

Healthpeak Properties, Inc.

Healthcare Realty Trust Incorporated

$7.07BUSD

CSH-UN

Chartwell Retirement Residences

$5.30BUSDP/E Infinity

SBRA

Sabra Health Care REIT, Inc.

$4.92BUSDP/E 31.0

NHI

National Health Investors, Inc.

Primary Health Properties Plc

$2.70BUSDP/E 13.7

MPT

Medical Properties Trust, Inc.

$2.76BUSD

DHC

Diversified Healthcare Trust

Sila Realty Trust, Inc.

$1.68BUSDP/E 44.6

NHP

National Healthcare Properties, Inc.

$1.08BUSD

CPINV

Care Property Invest NV

$578.96MUSDP/E 8.3

UHT

Universal Health Realty Income Trust

$608.58MUSDP/E 34.3

CHCT

Community Healthcare Trust Incorporated

$522.29MUSDP/E 152.3

XRN

Chiron Real Estate Inc.

$496.57MUSD

STRW

Strawberry Fields REIT, Inc.

$184.62MUSDP/E 21.5

Indicators:|

Key Statistics

Company

Market Cap6.41B $

Enterprise Value12.73B $

Revenue (TTM)425.31M $

Gross Profit378.87M $

Net Income (TTM)265.69M $

Revenue/Share8.550 USD

Last Price70.60 EUR

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees127

CountryBE

SectorReal Estate

IndustryREIT - Healthcare Facilities

ISINBE0003851681

Valuation

P/E (Trailing)6.14

P/E (Forward)12.82

PEG—

EV/EBITDA35.55

EV/Revenue29.93

P/S15.06

P/B0.88

EPS (TTM)11.49

EPS (Forward)5.51

52W Range

59.5054% of range80.05

52W High80.05 EUR

52W Low59.50 EUR

Profitability

Gross Margin94.16%

Oper. Margin80.17%

EBITDA Margin84.19%

Profit Margin66.03%

ROE6.67%

ROA3.77%

Growth

Revenue Growth23.40%

Earnings Growth481.10%

Cash Flow & Leverage

Operating CF345.48M $

CapEx (TTM)105.93M $

FCF Margin—

FCF Yield—

Net Debt5.41B $

Net Debt/EBITDA15.12

Balance Sheet

Debt/Equity0.70

Current Ratio0.11

Quick Ratio0.07

Book Value/Sh79.79 EUR

Cash/Share0.5390 EUR

Dividends

Fwd Div Rate4.000 EUR

Trail. Div Rate4.000 EUR

Div. Yield5.57%

5Y Avg Yield4.53%

Payout Ratio33.94%

Ex-Div DateMay 14, 2026

Pay Date—

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)83.00 EUR

Upside (mean)+17.6%

Target Range70.00 EUR – 94.00 EUR

€70.00+17.6% to mean€94.00

# Analysts10

Ownership

Shares Out.83.47M

Float83.42M

Insiders0.07%

Institutions37.04%

Technical

SMA 5070.54 (+0.1%)

SMA 20069.33 (+1.8%)

Beta0.96

S&P 52W Chg20.05%

Avg Vol (30d)142.50K

Avg Vol (10d)171.49K

Technical Indicators

RSI (14)53.6

MACD0.0507

MACD Signal-0.2872

MACD Hist.+0.3379

BB Upper71.75 EUR

BB Middle69.13 EUR

BB Lower66.51 EUR

BB Width7.58%

ATR (14)1.343 EUR

Vol Ratio (20d)2.01x